El Camino HIV Prevention and Care Study
Evaluating the Camino Intervention to Reduce HIV Risk and Poor Care Outcomes Among Latin Americans
Who can join
Ages 18 and older · Men
Full eligibility criteria
Inclusion Criteria: * Age 18 years or older * Assigned male sex at birth * Identifies as a Latin American man who has sex with men, transgender woman, or nonbinary person on the feminine spectrum * Not a U.S. citizen * Speaks Spanish or English * Resides in the Washington, DC metropolitan area or San Francisco Bay Area * Willing to receive health and/or supportive services through participating study partners * Willing to allow the study to obtain relevant medical record information * Meets one of the following HIV prevention or care criteria: * Living with HIV and either not linked to HIV care, has missed an HIV care appointment within the past year, is not taking antiretroviral therapy (ART), or has a detectable viral load; or Not living with HIV, is sexually active, and is either not taking pre-exposure prophylaxis (PrEP) or has not received an HIV test within the past 6 months Exclusion Criteria: * Younger than 18 years * Does not meet the inclusion criteria above
About the study
The Camino Study evaluates a status-neutral, multi-level pilot intervention designed to improve HIV prevention and care engagement among Latin Americans with unmet HIV prevention and care needs. The intervention combines legal services with peer navigation to reduce fear of healthcare engagement, reduce stress, and improve access to HIV prevention and care services.
The study will enroll 50 Latin American participants in the Washington, DC, and Oakland, California areas. Using a quasi-experimental wait-list control design, the study will compare HIV outcomes among participants who receive the Camino intervention with those on a rolling waitlist over 18 months. Primary outcomes include HIV testing within the past six months and uptake of pre-exposure prophylaxis (PrEP), as well as HIV care visit attendance, antiretroviral therapy (ART) adherence, and viral load among people living with HIV. The study will also examine legal, social, and mental health factors associated with HIV prevention and care engagement and assess the feasibility of testing the intervention at a larger scale.
What is being tested
- Camino Intervention (behavioral)
Sponsor: American University · Participants: 50 · Started: Jul 16, 2026
Contact the study team
Official record on ClinicalTrials.gov — NCT07834853
Locations in the U.S.
| California | Oasis Legal Services, Berkeley (Not yet recruiting) |
| District of Columbia | La ClÃnica del Pueblo, Washington D.C. |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.